Ashley Randolph to lead accounting at Genesco (NYSE: GCO)
Rhea-AI Filing Summary
Genesco Inc. has appointed longtime finance executive Ashley Randolph as Chief Accounting Officer and principal accounting officer. She will oversee accounting operations, financial controls and SEC reporting while supporting the company’s footwear-focused strategy.
Randolph, a 20-year Genesco veteran and CPA, most recently served as vice president and corporate controller. As part of her new role, she will receive an annual base salary of $278,000, with a target cash incentive of $83,400 for Fiscal 2027 under the Short-Term Incentive Plan and a target equity incentive of $139,000 under Genesco’s 2020 Equity Incentive Plan. She will also participate in the Executive Severance Plan and enter into an Employment Protection Agreement. Current President, CEO and Interim CFO Mimi E. Vaughn will cease serving as principal accounting officer once Randolph assumes the role but will continue as CEO and interim CFO.
Positive
- None.
Negative
- None.
8-K Event Classification
Key Figures
Key Terms
Chief Accounting Officer financial
Short-Term Incentive Plan financial
2020 Equity Incentive Plan financial
Executive Severance Plan financial
Employment Protection Agreement financial
Regulation FD Disclosure regulatory
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): |
(Exact name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction |
(Commission File Number) |
(IRS Employer |
||
|
|
|
|
|
|
||||
|
||||
(Address of Principal Executive Offices) |
|
(Zip Code) |
||
Registrant’s Telephone Number, Including Area Code: |
|
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
|
|
Trading |
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On May 5, 2026, Genesco Inc. (the “Company”) announced the appointment of Ashley Randolph as Chief Accounting Officer and principal accounting officer. Ms. Randolph will begin her employment as Chief Accounting Officer and principal accounting officer on April 30, 2026 (the “Effective Date”). As previously announced, on March 26, 2026, Mimi E. Vaughn, the Company’s President, Chief Executive Officer, Interim Chief Financial Officer and principal financial officer, was appointed by the Company’s board of directors to serve as the Company’s principal accounting officer until a successor is named by the Company. As such, as of the Effective Date, Ms. Vaughn will no longer serve as the Company’s principal accounting officer. Ms. Vaughn will continue to lead the Company’s experienced financial leadership team and management in connection with her service as Interim Chief Financial Officer.
Ms. Randolph, age 48, is a 20-year veteran of the Company, and most recently served as vice president and corporate controller, a role she has held since 2024. Ms. Randolph has served as senior director, finance and accounting, at the Company from 2018 to 2024 and director, finance and accounting from 2018 to 2016. Previously, Ms. Randolph served as director, operations financials, at Corizon Health, Inc. from August 2014 to August 2016. Prior to joining Corizon Health, Inc., Ms. Randolph served as director of technical accounting and financial compliance at the Company from June 2004 to August 2014. Prior to joining the Company in 2004, Ms. Randolph served as senior auditor with Deloitte & Touche LLP. Ms. Randolph holds a Bachelor of Arts in Accounting from Lipscomb University and is a certified public accountant.
In connection with her appointment, Ms. Randolph will receive an annual base salary of $278,000. Ms. Randolph will be eligible under the Company’s Short-Term Incentive Plan (as such plan may be amended from time to time) to receive a target incentive award for the fiscal year beginning February 1, 2026 (“Fiscal 2027”), equal to $83,400, or 30% of Ms. Randolph’s annual base salary for Fiscal 2027. Subject to the approval of the compensation committee of the Company’s board of directors, for Fiscal 2027, Ms. Randolph will be eligible to participate in the Company’s Third Amended and Restated 2020 Equity Incentive Plan, with Ms. Randolph’s target for Fiscal 2027 being equal to $139,000, which is equal to 50% of Ms. Randolph’s annual base salary for Fiscal 2027. Ms. Randolph will also become a participant in the Company’s Executive Severance Plan, and the Company and Ms. Randolph will enter into an Employment Protection Agreement.
There are no family relationships between Ms. Randolph and any director or executive officer of the Company, and the Company is not aware of any transactions with Ms. Randolph that are reportable pursuant to Item 404(a) of Regulation S-K. There are no legal proceedings required to be disclosed pursuant to Item 401(d) of Regulation S-K.
Item 7.01 Regulation FD Disclosure.
A press release issued by the Company announcing Ms. Randolph’s appointment is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information in this Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit No. |
Description |
99.1 |
Press Release, dated May 5, 2026. |
104 |
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
Genesco Inc. |
|
|
|
|
Date: |
May 5, 2026 |
By: |
/s/ Scott E. Becker |
|
|
|
Scott E. Becker |
EXHIBIT 99.1
GENESCO NAMES ASHLEY RANDOLPH VICE PRESIDENT AND CHIEF ACCOUNTING OFFICER
NASHVILLE, Tenn., May 5, 2026—Genesco Inc. (NYSE: GCO) today announced the appointment of Ashley Randolph as Vice President and Chief Accounting Officer, effective May 5, 2026. A 20-year veteran of Genesco, Randolph most recently served as Vice President and Corporate Controller, a role she has held since 2024.
In her new role, Randolph will oversee the Company’s accounting operations, financial controls and compliance, including financial statements, accounting policy, and SEC reporting, while driving continued efficiencies across the function.
“Ashley is a greatly respected leader whose deep institutional knowledge and strong financial expertise have contributed meaningfully to Genesco’s success,” said Mimi E. Vaughn, Genesco’s Board Chair, President, Chief Executive Officer and interim Chief Financial Officer. “Her proven track record, collaborative leadership style and commitment to excellence position her well to lead our corporate accounting organization as we continue to execute our footwear-first strategy and deliver value for our shareholders.”
During her tenure, Randolph has played a key role in strengthening Genesco’s financial foundation and advancing operational effectiveness, including leading the adoption of new accounting standards, modernizing SEC reporting processes and enhancing internal controls. She served as Senior Director, Finance and Accounting from 2018 to 2024 and Director, Finance and Accounting from 2016 to 2018. She held roles of increasing responsibility with the Company in technical accounting and financial compliance from 2004 to 2014. Prior to joining Genesco, Randolph was a senior auditor at Deloitte & Touche. She holds a bachelor’s degree in accounting from Lipscomb University and is a Certified Public Accountant.
EXHIBIT 99.1
GENESCO INC. --- Page 2
About Genesco Inc.
Genesco Inc. (NYSE: GCO) is a footwear first company with distinctively positioned retail and lifestyle brands and proven omnichannel capabilities offering customers the footwear they desire in engaging shopping environments, including more than 1,230 retail stores and branded e-commerce websites. Its Journeys, Little Burgundy and Schuh brands serve teens, kids and young adults with on-trend fashion footwear inspired by youth culture in the U.S., Canada and the U.K. Johnston & Murphy serves successful, affluent men and women with premium footwear, apparel and accessories in the U.S. and Canada, and Genesco Brands Group sells branded lifestyle footwear to leading retailers under licensed brands including Wrangler, Dockers and Starter. Founded in 1924, Genesco is based in Nashville, Tennessee. For more information on Genesco and its operating divisions, please visit www.genesco.com.
Genesco Media Contact
Claire S. McCall, Director, Corporate Relations
(615) 367-8283 / cmccall@genesco.com